Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Curious about Gilead (GILD) Q1 Performance? Explore Wall Street Estimates for Key Metrics
10:16am, Monday, 04'th May 2026
Get a deeper insight into the potential performance of Gilead (GILD) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some o
Can You Sue A Drug Company For Not Inventing Faster?
05:15am, Monday, 04'th May 2026
This week, the California Supreme Court is set to hear a case that could have far-reaching consequences for medical science.
Wall Street Week Ahead
06:51am, Sunday, 03'rd May 2026
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Should You Buy, Hold, or Sell GILD Stock Ahead of Q1 Earnings?
03:10pm, Friday, 01'st May 2026
Gilead Sciences gears up for Q1 earnings with HIV drugs driving growth, but cell therapy headwinds and rising costs could shape the outlook.
Gilead Sciences to Present at Upcoming Second Quarter 2026 Investor Conferences
06:00am, Friday, 01'st May 2026
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #GILD--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: BofA Securities Health Ca
Gilead Sciences (GILD) Outperforms Broader Market: What You Need to Know
06:51pm, Thursday, 30'th Apr 2026
Gilead Sciences (GILD) closed at $130.84 in the latest trading session, marking a +1.55% move from the prior day.
Gilead Sciences (GILD) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Thursday, 30'th Apr 2026
Gilead (GILD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
10:01am, Thursday, 30'th Apr 2026
Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
07:21am, Thursday, 30'th Apr 2026
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund lau
Gilead Sciences, Inc. $GILD Stock Holdings Lifted by D.A. Davidson & CO.
02:20pm, Wednesday, 29'th Apr 2026
D.A. Davidson and CO. lifted its holdings in Gilead Sciences, Inc. (NASDAQ: GILD) by 8.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 66,
U.S. FDA Grants Priority Review of New Drug Application for Gilead's Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir
08:30am, Wednesday, 29'th Apr 2026
FOSTER CITY, Calif.--(BUSINESS WIRE)-- #GILD--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) submission for bi
Amgen to Report Q1 Earnings: Can It Keep the Beat Streak Alive?
01:15pm, Tuesday, 28'th Apr 2026
Amgen heads into Q1 earnings with growth from key drugs offset by pricing pressure, patent losses, and biosimilar competition.
Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel
08:45am, Tuesday, 28'th Apr 2026
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the successful completion of its previously announced acquisition of Arcellx, Inc. (Nasdaq: ACLX). Under the
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
07:20am, Tuesday, 28'th Apr 2026
The iShares Biotechnology ETF (IBB) was launched on 02/05/2001, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
3 Healthcare Stocks That Pay You While You Wait for the Growth
07:45pm, Monday, 27'th Apr 2026
It may not seem like it at first, but these dividends are safe.
